39 participants
Nivolumab Plus Rituximab in First-line Follicular Lymphoma gr 1-3A
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-07-30
- Start Date:
- 2017-09-07
- Completion:
- 2022-05-11
Conditions
- Follicular Lymphoma
Interventions
- DRUG
No Results Yet